Background {#Sec1}
==========

Recent studies from Ghana and other sub-Saharan African countries indicate that the prevalence of cardiovascular diseases (CVDs) is increasing at an alarming rate \[[@CR1], [@CR2]\]. A recent meta-analysis reported that CVDs in sub-Saharan Africa cause a million deaths, constituting 38.3% of non-communicable disease deaths, and 11.3% of deaths from all causes \[[@CR3]\]. CVDs are associated with constellation of cardio-metabolic risk factors including dyslipidaemia, hypertension, hyperglycaemia and central obesity, generally referred to as Metabolic syndrome (MetS) \[[@CR4]\]. Several studies have reported the prevalence of MetS in adults from general and diseased populations in sub-Saharan Africa. The prevalence of the MetS in urbanised sub-Sahara African population ranges from 11% in Benin \[[@CR5]\] to 34.6% in Kenya \[[@CR6]\]. In most studies, the prevalence of MetS varies with gender, age, ethnicity and geographical location. MetS in young adulthood is a strong predictor of future CVDs \[[@CR7], [@CR8]\], and reversing components of MetS may be protective against CVDs in adulthood \[[@CR9]\]. This observation suggests that early screening and treatment of components MetS may be beneficial in the amelioration of the complications associated with this syndrome. However, there is paucity of data on the prevalence of the MetS in young adults in Ghana or other indigenous West African countries.

Individuals with a positive parental history of CVD, particularly if premature at onset, is a widely accepted risk factor for cardiovascular events. Recent guidelines recommend consideration of a positive parental history of premature coronary heart disease when deciding whether to initiate antihyperlipidemic or antihypertensive therapy for primary prevention. In the Atherosclerosis Risk in Communities study, conducted in middle-aged adults (45--65 years), parental history of diabetes/hypertension in both parents was associated with 8-fold increase in the likelihood of MetS in offspring \[[@CR10]\]. It is, however, uncertain how parental history of CVD may affect MetS in young adults in sub-Saharan Africa. The prevalence of MetS varies with gender, and females are more likely to know the CVD history of their parent. In this study, we assessed the gender-specific prevalence of MetS in urban Ghana, and the association of parental history of CVDs on the prevalence of MetS. We hypothesise that, compared to those without parental history of CVDs, young adults from parents with history of CVDs will have higher levels of MetS.

Methods {#Sec2}
=======

Setting, design and population {#Sec3}
------------------------------

The study was a cross-sectional design conducted among young adults in Accra, from November 2015 through May 2016. Accra is the capital of Ghana and is located in the Greater Accra Region. Geographically, Accra is bounded on the north by latitude 5 41.4 N, on the south by the Gulf of Guinea, on the east by Longitude 00 01E and on the west by Longitude 00 21.5 (Fig. [1](#Fig1){ref-type="fig"}). According to the Ghana Demographic and Health survey, Accra has the highest prevalence of hypertension in Ghana.Fig. 1Map of study location, Accra, Ghana. (Credit: Michael Atta Kyereh, Web Design Ghana)

The study participants were male and female young adults within the age range of 20--30 years, recruited from University of Ghana. Potential participants were invited electronically through SherlockMD online application ([www.sherlockmd.org](http://www.sherlockmd.org)). Out of 556 electronic invitations sent, 408 responded favourably, of which 382 met the eligibility criteria. However, 370 participants were able to visit the study centre for clinical measurements and blood sample collection. During analysis, four participants were excluded due to incomplete data. Participants uncertain of their parent's CVD status, and those already diagnosed with diabetes, hypertension, hyperlipidaemia, renal disease, overt cardiovascular disease were excluded from the study. The study was conducted in conformity with the Helsinki Declaration on Human Experimentation, 1964 with subsequent revisions, latest Seoul, October 2008. Institutional approval was granted by the Ethical and Protocol Review Committee of the College of Health Sciences, University of Ghana (MS-ET/M.3-P3.3/2015--2016).

Lifestyle and health data {#Sec4}
-------------------------

After informed consent, a structured questionnaire was used to collect socio-demographic and lifestyle data (age, gender, personal and family medical history, smoking and alcohol intake). A positive parental history of diabetes, hypertension or CVD was documented as responding yes to these questions: "Has your mother/father ever been diagnosed as diabetic or on anti-diabetic drug?" or "Has your mother/father ever been diagnosed as having high BP or on antihypertensive drug?" or "Has your mother/father ever been diagnosed as having any of the following heart/blood vessel disease or on treatment for this disease?" Parental CVDs (heart/blood vessel disease) were defined as either mother or father having one of the following: stroke, angina, heart attack, heart disease, limb amputation that is not through accident and vascular surgery.

Anthropometry and blood pressure {#Sec5}
--------------------------------

Weight, height, waist and hip circumferences were measured using standard protocol \[[@CR11]\]. Briefly, body weight was determined on twice using a homologated electronic scale (Seca 770) following due calibration (precision ±0.1 kg), with the patient wearing light clothing with shoes removed. Height was also measured with a portable system (Seca 222) with the patient shoeless in the upright position. Body mass index (BMI) was computed as weight (kg) divided by height squared (m^2^). Percentage body fat and visceral fat were estimated through bioelectrical impedance analysis with the Body composition monitor (BF- 508, Omron Healthcare, Inc., Vernon Hills, IL, USA). Waist circumference was measured with non-elastic tape measure at the upper border of the iliac crest, parallel to the floor without compressing the skin. Blood pressure (BP) was measured after 5 mins rest, with participant in seated position with a back support, using with automated BP monitor (HEM-705CP; Omron Corporation, Tokyo, Japan). Three different measurements were taken and the last two averaged for analysis.

Biochemical analysis {#Sec6}
--------------------

After 8--12 h of overnight fasting, approximately 10 ml of venous blood was drawn from the antecubital fossa into appropriate tubes. The samples were centrifuged and the serum/plasma aliquoted for analysis. Fasting plasma glucose (FPG), total cholesterol, high-density (HDL) lipoprotein cholesterol, triglyceride, plasma urea and serum creatinine levels were analysed using chemical autoanalyser (Mindray BS 200, China) and commercial reagents (Randox Laboratory Reagents, UK). Low-density lipoprotein (LDL) cholesterol levels were calculated using Friedewald's formula.

Definition of MetS {#Sec7}
------------------

MetS was defined, according to the Joint Scientific Statement criteria \[[@CR4]\], as individuals with any three or more of the following five components: (1) abdominal obesity (waist circumference ≥ 94 cm for men & ≥ 80 cm for women); (2) high triglycerides ≥1.7 mmol/L; (3) low HDL cholesterol: men \<1.0 mmol/L or women \<1.3 mmol/L; and (4) High BP (systolic BP ≥ 130 mmHg and/or diastolic BP ≥ 85 mmHg); and (5) impaired fasting glucose ≥5.6 mmol/l.

Statistical analysis {#Sec8}
--------------------

The data was analysed using IBM SPSS version 20 software. Gender comparison of anthropometric indices, biochemical analytes, socio-demographic and health variables were performed using student's *t*-test for continuous variables and Pearson's *χ* ^2^ test for categorical variables. Association between components of MetS and parental diabetes, hypertension and CVDs were analysed as Pearson's χ^2^, with Fisher adjustment or Yate's continuity correction when appropriate. Univariate and multivariable logistic regression models were used to analyse the change in odds of MetS and parental diabetes, hypertension and CVDs. *p* \< 0.05 was considered statistically significant.

Results {#Sec9}
=======

The prevalence of MetS in our study participants was 12.4%, higher in females than males. Male participants had higher proportions of current and previous alcohol and smoking status, generally taller with higher waist-hip ratio and serum creatinine levels. Female participants had higher proportions of family history of diabetes, hypertension and CVDs; higher mean levels of BMI, hip circumference, FPG, systolic, diastolic, mean & pulse BPs (Table [1](#Tab1){ref-type="table"}). The prevalence of components of MetS in our study participants are as follows: high systolic BP 35.6%, low HDL cholesterol 30.9%, impaired fasting glucose 18.2%, abdominal obesity 17.1% and hypertriglycerimia 1%. Compared to males, female participants had higher prevalence of abdominal obesity, high BP and low HDL cholesterol (Fig. [2](#Fig2){ref-type="fig"}). In addition, female participants had greater accumulation (≥2) of components of MetS (Fig. [3](#Fig3){ref-type="fig"}).Table 1General characteristics of study participants by genderAll participants (*n* = 364)Males (*n* = 174)Females (*n* = 190)*p*Age, years24.9 ± 2.925 ± 2.724.7 ± 3.10.569Smoking status, n (%) Current26 (7.1)23 (13.2)3 (1.6)\<0.001 Former39 (10.7)32 (18.4)7 (3.7)0.03 Never299 (82.1)119 (68.4)180 (94.7)0.74Alcohol status, n (%) Current77 (21.1)59 (33.9)18 (9.5)\<0.001 Former87 (23.9)67 (38.5)20 (10.5)0.03 Never200 (54.9)48 (27.6)152 (80)\<0.001Parental history of CVDs, n (%) Diabetes60 (16.5)23 (13.2)37 (19.5)0.032 Hypertension74 (20.3)26 (15)48 (25.3)0.017 Cardiovascular diseases90 (24.7)16 (9.2)74 (38.9)\<0.001Weight, kg69.2 ± 9.968.1 ± 8.970.1 ± 10.70.054Height, cm167 ± 7168 ± 7166 ± 6\<0.001BMI, kg/m^2^24.9 ± 3.824.1 ± 3.325.6 ± 4\<0.001Waist circumference, cm88 ± 1689 ± 1686 ± 170.135Hip circumference, cm98 ± 1696 ± 1699 ± 150.025Waist-hip ratio0.91 ± 0.190.94 ± 0.20.88 ± 0.180.002Body fat, %26.7 ± 8.725.2 ± 7.628.1 ± 9.30.001Visceral fat, %5.6 ± 3.75.3 ± 3.54.6 ± 0.90.115Systolic BP, mmHg116 ± 12113 ± 11119 ± 13\<0.001Diastolic BP, mmHg75 ± 974 ± 876 ± 100.002Pulse BP, mmHg41 ± 840 ± 842 ± 8\<0.001Mean BP, mmHg89 ± 987 ± 891 ± 10\<0.001FPG, mmol/l4.9 ± 1.14.6 ± 0.95.2 ± 1.3\<0.001Triglycerides, mmol/l1.5 ± 0.41.5 ± 0.41.6 ± 0.40.082Total cholesterol, mmol/l5.2 ± 1.15.2 ± 1.25.1 ± 10.389HDL cholesterol, mmol/l1.1 ± 0.51.1 ± 0.41.1 ± 0.50.877LDL cholesterol, mmol/l3.6 ± 1.33.6 ± 1.33.6 ± 1.30.944vLDL cholesterol, mmol/l0.35 ± 0.150.34 ± 0.130.35 ± 0.170.505Urea, mmol/l3.4 ± 0.83.5 ± 0.93.4 ± 0.80.197Creatinine, mmol/l91 ± 1694.8 ± 17.988.5 ± 14.50.001Metabolic syndrome, %45 (12.4)10 (5.7)35 (18.4)0.019*CVDs* cardiovascular diseases, *BMI* body mass index, *BP* blood pressure, *FPG* fasting plasma glucose, *HDL* high density lipoprotein, *LDL* low density lipoprotein, *vLDL* very low density lipoprotein Fig. 2Gender-specific prevalence of components of metabolic syndrome. Data were analyzed using Pearson's χ^2^ with Fisher adjustment or Yate's corrections when appropriate. Compared to male participants, female participants had higher prevalence of abdominal obesity (8.7% vs 26.4%, *p* = 0.002), low HDL (15.8% vs 42.3%, *p* \< 0.001) Fig. 3Number of components of metabolic syndrome by gender. Data were analyzed using Pearson's χ^2^ with Fisher adjustment or Yate's corrections when appropriate. Compared to females, greater proportion of males were without any components metabolic syndrome (56.7% vs 35.9%, *p* = 0.003). Compared to males, greater proportion of females had two (19.1% vs 4.2%, *p* \< 0.001) or three (13.9% vs 3.1%, *p* = 0.005) components of metabolic syndrome

Abdominal obesity was associated with parental CVDs, diabetes and hypertension in the entire study participants. In male participants, parental history of CVDs was associated with low HDL cholesterol. In females, low HDL cholesterol level was associated with parental history of CVDs, diabetes and hypertension. Also, high BP and impaired fasting glucose were associated with parental diabetes (Table [2](#Tab2){ref-type="table"}). In the entire study participants, parental diabetes, hypertension and CVDs were associated increased change in odds of MetS in unadjusted logistic regression models. After adjustment for various risk factors, only parental CVDs was associated with increased change in odds of MetS. In female participants, parental history of diabetes, hypertension and CVDs were associated with increased in odds of MetS in unadjusted logistic regression models. After adjustment for confounders, the association between MetS and parental hypertension and CVDs still remained significant. MetS in male participants was not associated with parental history of diabetes, hypertension and CVDs (Table [3](#Tab3){ref-type="table"}).Table 2Components of metabolic syndrome and parental CVDs, diabetes and hypertensionParental CVDsParental diabetesParental hypertensionAbsentPresent*p*AbsentPresent*p*AbsentPresent*p*All participants (*n* = 364) High BP95 (34.8)35 (39.1)0.469106 (34.8)23 (38.7)0.608101 (34.7)29 (39.3)0.485 Low HDL81 (29.7)32 (35.9)0.28690 (29.7)22 (37.1)0.27986 (29.6)28 (37.7)0.175 Abdominal obesity42 (15.2)23 (25)0.02846 (15.2)16 (25.8)0.29844 (15.2)19 (26.2)0.033 IFG50 (18.1)17 (18.8)0.91455 (18.1)12 (19.4)0.72753 (18.4)13 (18)0.887 Hypertriglycerimia1 (1.1)3 (3.6)0.0590 (0)0 (0)0 (0)0 (0)Males (*n* = 174) High BP37 (23.4)5 (31.3)0.48541 (27.2)6 (16.2)0.91521 (14.2)7 (26.9)0.1 Low HDL9 (6)5 (31.3)0.00111 (7.3)3 (8.1)0.34414 (9.5)2 (7.7)0.774 IFG18 (11.4)3 (18.8)0.38915 (9.9)2 (5.4)0.85211 (7.4)4 (15.4)0.183Females (*n* = 190) High BP58 (50)30 (40.5)0.20241 (27)17 (45.9)0.02362 (43.7)22 (45.8)0.793 Low HDL72 (62.1)28 (37.8)0.00127 (17.6)19 (51.4)\<0.00130 (21.1)26 (54.2)\<0.001 Abdominal obesity42 (36.2)23 (31.1)0.46846 (15.2)16 (25.8)0.12553 (18.4)13 (18)0.198 IFG32 (27.6)14 (18.9)0.17421 (13.7)10 (27)0.04917 (12)9 (18.8)0.238Data were analyzed as Pearson's χ^2^ with Fisher adjustment or Yate's corrections when appropriate*BP* blood pressure, *HDL* low density lipoprotein cholesterol, *IFG* impaired fasting glucose Table 3Logistic regression models of metabolic syndrome versus parental diabetes, hypertension and CVDsUnadjusted OR (95% CI)*p*Adjusted OR (95% CI)^a^*p*All participants Parental diabetes1.14 (1.09--2.06)0.0311.01 (0.89--3.87)0.152 Parental hypertension1.61 (1.17--2.94)0.0181.18 (1.01--2.12)0.054 Parental CVDs2.11 (1.41--4.76)\<0.0011.23 (1.12--3.04)0.037Males Parental diabetes2.36 (0.54--4.12)0.4871.41 (0.31--8.91)0.561 Parental hypertension2.81 (0.72--5.62)0.2381.87 (0.81--7.02)0.421 Parental CVDs1.59 (0.62--3.11)0.2041.92 (0.51--3.68)0.384Females Parental diabetes1.32 (1.11--2.65)\<0.0011.17 (0.94--2.97)0.091 Parental hypertension2.01 (1.12--3.14)\<0.0011.41 (1.07--2.85)0.026 Parental CVDs2.24 (1.08--5.01)\<0.0011.51 (1.14--4.52)0.017Data analyzed using binary logistic regression for unadjusted odds ratio and multivariable regression for adjusted odds ratio*OR* odds ratio, *CVDs* cardiovascular diseases^a^adjusted for age, gender, alcohol intake and smoking status

Discussion {#Sec10}
==========

The prevalence of MetS in this study, conducted in young adults in urban Ghana, is 12.4%, higher in females than male participants. Because the hypothesis being tested requires knowledge of parental diabetes, hypertension and CVDs status, tertiary student were suited as participants in this study. It should, however, be noted that, the prevalence of high BP and obesity in our study were similar to what was reported in non-tertiary young adults from poor neighbourhood in Accra \[[@CR12]\]. This indicate an alarming rate of high BP in young adults in urban Ghana.

From our literature search, this is the first study to report MetS in young adults resident in West Africa. Studies reports from western nations have pegged the prevalence of MetS in young adults within the range similar to our findings. For instance, the in the United States, the National Health and Nutrition Examination Survey (NHANES) III reported the prevalence of MetS in young adults aged 20--29 years to be 6.7% \[[@CR13]\], the Bogalusa Heart Study \[[@CR14]\] reported 13% and the NHANES III depression study \[[@CR15]\] reported 7.8%. In Europe, studies conducted in Finland \[[@CR16]\] and Northern Ireland \[[@CR17]\] reported prevalence to be 5.8 and 10.6% respectively. Studies conducted in developing countries such as Turkey \[[@CR18]\] and Jamaica \[[@CR19]\] reported prevalence of MetS in young adults to be 3.6 and 1.2% respectively. The studies above reported inconsistencies in gender-specific prevalence in MetS. Similar to our findings, female participants had a higher prevalence of MetS in Jamaica and Turkey studies \[[@CR18], [@CR19]\]. The Bogalusa and Irish studies reported similar prevalence among male and female participants \[[@CR14], [@CR17]\], while the NHANES and Finish studies reported higher prevalence in male participants \[[@CR13], [@CR16]\]. The prominent components of MetS in our study were high BP, low HDL cholesterol and abdominal obesity. These components were common in female participants than males participants, similar to what was reported in Turkish study \[[@CR18]\]. In Jamaican young adults, compared to female participants, male participants had higher proportion of high BP, lower proportion of abdominal obesity and low HDL cholesterol \[[@CR19]\].

Systematic review and meta-analysis have demonstrated that presence of MetS is associated with a twofold increase in composite CVD, stroke, myocardial infarction and all-cause mortality \[[@CR20]\]. The risk of CVD mortality associated with MetS is greater than the risk associated with individual components of MetS, suggesting that individuals with the constellation of metabolic abnormalities that characterise MetS should be targeted for aggressive primary prevention. It has also been shown that development of components of MetS in childhood can be tracked into adolescence and adulthood \[[@CR21]\], emphasising the essence of early screening of MetS in CVD prevention \[[@CR22]\]. Additionally, the commonest components of MetS in our study, increased BP and dyslipidemia, have been shown to be strong predictors of vascular events \[[@CR23]\].

The findings of this study indicate that abdominal obesity was associated with parental CVDs, diabetes and hypertension in all participants. A positive parental history of CVDs was associated with increase in the likelihood of MetS in offspring after adjustment for confounders. Parental history of CVD may reflect the genetic, biochemical, and behavioural factors which may predispose an individual to a higher risk of CVD \[[@CR24]\]. In the Family Heart study, family history of obesity, diabetes and hypertension were associated with MetS \[[@CR25]\]. In female participants in the current study, low HDL cholesterol was associated with parental diabetes, hypertension and CVDs. Also, high BP and dysglycaemia were associated with parental diabetes. Similar findings were reported in the Framingham Heart and Offspring Cohorts study, in which there was association in systolic BP, plasma total cholesterol, HDL cholesterol and BMI between parent and offspring, as well as siblings \[[@CR26]\]. This indicates that young adults from parents with CVDs should be monitored and treated for MetS to reduce the risk of developing CVDs in the future.

Limitations of the study {#Sec11}
------------------------

This study was conducted in young adults in urban Ghana, and hence, the findings may differ from peri-urban and rural population; generalisation cannot be made for the entire Ghanaian population. We cannot infer causation from the findings of the study due to the cross-sectional design. The data on parental history of diabetes, hypertension and CVDs may be affected by recall bias, which may lead to misclassification of some study participant. In this study, compared to males, more females reported positive parental history of diabetes, hypertension and CVDs. This might be attributed to gender-based recall bias in the assessment of parental medical history. In Ghana, due to superstitious beliefs attached to chronic diseases like diabetes, hypertension and CVDs \[[@CR27]\], many parents may fail to disclose unrecognized disease to close family members, even their children. Young women, however, due to their traditional responsibility of cooking and caring for their aged parents, as well as accompanying them to the hospital and supporting them to adhere to their medications and dietary regimen, are more likely to be aware of their parent's CVD status. Such information bias and the subsequent differential misclassification of parental CVD status may clearly impair the findings of this study.

Conclusion {#Sec12}
==========

In our study population aged between 20 and 29 years, the prevalence of MetS is 12.4%, higher in females than male participants. Parental history of CVDs was associated with MetS, especially in female participants.
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